INTRODUCTION
Cobalamin (Cbl) neuropathy has been produced in several animal models, including the monkey (Agamanolis et al., 1976; Scott et al., 1981) , fruit bat (Green et al., 1975) and, most recently, the pig (Weir et al., 1988) . In these the development of neuropathy has been considerably ameliorated by adding methionine to the diet (Scott et al., 1981 ; Van der Westhuyzen et al., 1982; Weir et al., 1988) . The synthesis de novo of methionine requires Cbl as a coenzyme, and hence it was suggested that the defect in Cbl function producing neuropathy was in relation to an impairment of methionine metabolism.
The second biochemical pathway in mammals requiring Cbl is the conversion of methylmalonic acid (MMA) to succinic acid. MMA is derived from various precursors, including valine. Recently it has been found that the neuropathy in the Cbl-deficient cape fruit bat (Rousettus aegyptiacus) is ameliorated by valine (VieiraMakings et al., 1989) , casting some doubt as to which pathway is involved in the development of neuropathy.
Much of the available methionine is converted into Sadenosylmethionine (AdoMet), which is a general donor of methyl groups in transmethylation reactions. Arnstein & Neuberger (1953) showed that Cbl was required for methyl-group synthesis and for the normal transfer of methyl into choline (transmethylation). Impaired transmethylation has remained a possible explanation for some of the consequences of Cbl deficiency, including neuropathy (Scott et al., 1981) . However, the concentration of AdoMet in the brain of Cbl-deficient animals, including those dying with Cbl neuropathy, is generally normal or is even raised (Lumb et al., 1983 ; Van der Westhuyzen & Metz, 1983) . This has made it less likely that impairment of transmethylation was involved. Indeed, McLoughlin & Cantrill (1986) found no change in labelled-methyl-group incorporation into brain phospholipids in Cbl-deficient fruit bats and no change in synaptosomal and myelin lipid methylation. Further, there was no impairment of methylation of arginine in myelin basic protein from fruit bats dying of Cbl neuropathy (Deacon et al., 1986) .
After methyl-group transfer, AdoMet is converted into AdoHcy (S-adenosylhomocysteine), AdoHcy loses its adenosine group and the homocysteine remaining is regenerated into methionine by accepting a methyl group from methyl-Cbl (methionine synthetase reaction). This pathway is largely non-functional in Cbl deficiency. Thus brain has no mechanism for disposing of homocysteine. AdoHcy, by inhibiting transmethylation reactions, is held to be toxic. AdoHcy competes with AdoMet for binding sites on transmethylating enzymes. Elevation of AdoHcy levels was present in nerve tissues from Cbldeficient pigs, and stress was laid on the decreased AdoMet/AdoHcy ratio, which was significantly lower than that in controls (Weir et al., 1988 cyano-Cbl/kg body wt.) every 2 weeks to maintain normal vitamin B12 status. Groups
The bats were randomly divided into four groups: one control and three experimental groups, each comprising four animals. The experimental groups were depleted of vitamin B12 and received the standard fruit diet, either unsupplemented (group 1) or supplemented with Lmethionine (99 %, E. Merck, Darmstadt, Germany) in the proportion of 0.6 g/kg of fruit (group 2) or with Lvaline (99 %, Riedel-de Haen) in the proportion of 0.4 g/kg of fruit (group 3) or in the proportion of 0.55 g/kg of fruit (group 4) throughout the study. The methionine and valine were equimolar.
Experimental procedure
The protocol for this study was approved by the Animal Ethics Committee of the University of Witwatersrand, Johannesburg, South Africa. Before commencement of the experiment, all the bats were examined clinically, sexed and weighed. Animals were bled by cardiac puncture for measurement of vitamin B12 by radioisotopic dilution assay (Simultrac-SNB kit; Becton-Dickinson, New York, NY, U.S.A.). The bats were bled again at 6 weeks, 12 weeks and 18 weeks, at which time the experiment was terminated. The three experimental groups were depleted of vitamin B12 by exposure to an atmosphere of nitrous oxide (N20)/02 (1:1) for 90 min/day in a specially constructed environmental chamber in which water vapour and CO2 were controlled (Arnstein & Neuberger, 1953) . After the exposure period the bats were returned to their cages. Animals were examined weekly for development of neurological impairment. Flight characteristics were also recorded. After 6 weeks of N20 exposure the experimental animals were vitamin B12-deficient and exposure to N20 was stopped. These animals continued to receive (40-80 4tl) were injected directly into the h.p.l.c. system, separation of both AdoMet and AdoHcy occurring within 14 min (Fig. 1) 
RESULTS
The data (Tables 1 and 2) /g ). There were no other significant changes.
DISCUSSION
The pig showed marked falls in AdoMet/Adohcy ratios when Cbl-deficient and developed neuropathy. The Cbl-deficient rat showed a smaller fall in ratio without developing any neuropathy. This study shows that neuropathy develops in the Cbl-deficient fruit bat without any change at all in AdoMet/AdoHcy ratios. It is clear that the development of neuropathy is unrelated to methylation, confirming other studies outlined in the Introduction.
Methionine can influence Cbl metabolism in other ways than just providing methyl groups (Chanarin et al., 1985 (Chanarin et al., , 1989 ) (Scheme 1). Methionine is a precursor of polyamines. A product of this pathway is 5'-methylthioadenosine, which is reconverted into methionine and 'active' formate. Formate from this source joins the single-carbon-unit pool and is donated via the folate coenzyme in the synthesis of adenine and guanine. 5'-Methylthioadenosine, indeed, is more active than methionine in overcoming Cbl deficiency. Methionine is thus a source of formate and this can be impaired in Cbl deficiency. In the rat at least, Cbl deficiency leads to considerable impairment in the utilization of formate. The evidence can be summarized as follows: (1) Thus it would seem sensible to explore formate metabolism in Cbl-deficient brain, and the defect in the brain may be essentially the same as that found in liver and marrow cells.
The amelioration of Cbl neuropathy by valine does put a defect of MMA metabolism in the central nervous system back into play, and this aspect, too, needs exploration. As valine supplementation would aggravate a lesion in the MMA pathway, the effect of valine is at present difficult to understand. 
